Palo Alto, CA, United States of America

Demir Akin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Illinois. Active years: 2015.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Demir Akin: Innovator in DNA Sequencing Technologies

Introduction

Demir Akin is a prominent inventor based in Palo Alto, California. He has made significant contributions to the field of biotechnology, particularly in DNA sequencing and amplification systems. His innovative work has the potential to advance the capabilities of biochemical sensing and molecular detection.

Latest Patents

Demir Akin holds a patent for "DNA sequencing and amplification systems using nanoscale field effect sensor arrays." This patent describes field effect chemical sensor devices that are useful for chemical and biochemical sensing. Additionally, it outlines methods for single molecule detection and amplification of target molecules through PCR techniques. He has 1 patent to his name.

Career Highlights

Akin is affiliated with the University of Illinois, where he continues to push the boundaries of research in his field. His work has garnered attention for its innovative approach to enhancing DNA sequencing technologies.

Collaborations

Demir Akin has collaborated with notable colleagues, including Rashid Bashir and Donald E. Bergstrom. Their combined expertise contributes to the advancement of research in biotechnology and sensor technologies.

Conclusion

Demir Akin's contributions to DNA sequencing and amplification systems highlight his role as an influential inventor in the field of biotechnology. His innovative approaches and collaborations continue to pave the way for future advancements in molecular detection technologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…